Monday, July 9, 2018

KemPharm pushes ADHD filling to 2019 - BioPharma Dive


Benzinga

KemPharm pushes ADHD filling to 2019
BioPharma Dive
SKAMP is a rating of classroom behaviors in children with ADHD and PERMP is a math test designed to asses a child's ability to initiate, self-monitor and complete the test. The company intends to submit a New Drug Application for the ADHD prodrug in ...
KemPharm's ADHD Candidate Meets Efficacy, Safety Trial EndpointsBenzinga
KemPharm's KP415 successful in late-stage ADHD study; shares ahead 7% premarketSeeking Alpha
KemPharm Dips Despite Positive ADHD Trial Results24/7 Wall St.
GlobeNewswire (press release) -StreetInsider.com
all 14 news articles »

No comments:

Post a Comment